Navigation Links
Keith Denner Extends Current Technology's Chairman and CEO Options

VANCOUVER, British Columbia, April 10 /PRNewswire-FirstCall/ -- On July 6, 2006, Current Technology Corporation (the "Company") announced that Keith Denner had granted to the Chairman and to the Chief Executive Officer, for nominal consideration, options ("Options") to purchase common shares in the capital of the Company, from his personal holdings, under the following terms and conditions:

i) total number of shares under option -- 3,000,000;

ii) exercise price -- $0.38 (all funds USD) per share;

iii) vesting -- fifty percent of the options to vest if the Company's

shares close at $0.78 or higher, and the remaining fifty percent to

vest if they close at $1.14 or higher;

iv) term -- the option to expire on July 5, 2008;

v) Mr. Denner to have the right to donate all or a portion of the

3,000,000 shares to a charity or charities, subject to the terms of

the option agreements; and

vi) Robert Kramer must be an officer of the Company at the time of

exercise of the option.

The Company's Board of Directors has reviewed the terms of the options and confirmed they are fair to the Company and that no consideration was provided by the Company to Mr. Denner to induce him to grant the options.

"I have been and remain a long-term supporter of the Company," stated Mr. Denner. "I believe it is in the shareholders' best interests to incentivize the Chairman and CEO of the Company and I am pleased to do my part by offering a portion of my personal holdings to that end. I am very supportive of the Company's recent acquisition of a controlling interest in Celevoke, Inc. and feel it appropriate to extend the term of my option to Mr. Kramer for another year to July 5, 2009."

Mr. Denner owns 16,619,266 common shares (representing approximately 12.83% of the issued and outstanding shares of the Company) and warrants to purchase an additional 27,548,933 common shares. In addition, Mr. Denner holds a convertible promissory note in the principal amount of $1,166,156 issued by the Company. In the aggregate, after giving effect to the exercise of Mr. Denner's warrants and the conversion of the convertible promissory note (and prior to the exercise or conversion of any options, warrants or other convertible securities of the Company by any other holder thereof), Mr. Denner would beneficially own 33.09% of the outstanding shares of the Company. This percentage will be reduced proportionately if other holders exercised their existing options and warrants previously issued by the Company.

Prior to the grant of the Options, Robert Kramer directly held 1,854,337 common shares in the capital of the Company, warrants to purchase an additional 4,250,000 common shares and 7,000,000 options previously granted by the Company. Indirectly through companies 100% controlled by Mr. Kramer, he holds an additional 2,392,666 common shares in the capital of the Company. In the aggregate, after giving effect to the exercise of all previously issued options and warrants held by Mr. Kramer, but prior to the exercise of the Options, he would beneficially own or control 15,497,003 common shares in the capital of the Company, representing 11.01% of the issued and outstanding common shares in the capital of the Company. After giving effect to the exercise of the Options, Mr. Kramer would beneficially own or control 18,497,003 common shares in the capital of the Company, representing 12.87% of the issued and outstanding common shares in the capital of the Company. All of the foregoing numbers are effective as of April 10, 2008.

The Options were acquired in a private transaction for investment purposes only and Mr. Kramer does not have any present intention to further increase his beneficial ownership of, or control or direction over, additional common shares in the capital of the Company. Mr. Kramer may in the future take such actions in respect of his holdings that he deems appropriate in light of the circumstances then existing, including the purchase of additional common shares or other securities of the Company through open market purchases or privately negotiated transactions, or the sale of all or a portion of his holdings in the open market or in privately negotiated transactions.

SOURCE Current Technology Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
2. Therap Services Welcomes Anna Keith to the US Customer Support Team
3. Viant Appoints Keith Vangeison as Executive Vice President of Network Development
4. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
5. Keith Taft Named General Manager of UltraTape Industries
6. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
7. The Quantum Group Extends CEOs Employment Agreement
8. Hands on Disaster Response Extends Cyclone Relief Project
9. PROGNOSIS Extends its Popular IP Telephony Management Software to Support Nortel Environments
10. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
11. Actavis Extends Portfolio With Four New Products in the U.S.
Post Your Comments:
(Date:11/26/2015)... Bangalore, Karnataka (PRWEB) , ... ... ... an innovative online platform for mental health and wellness consultation, has collaborated ... self-empowerment, to holistically address their reader’s queries on topics on mental and ...
(Date:11/25/2015)... Indianapolis, IN (PRWEB) , ... November 25, 2015 ... ... clean water accessible for all, Water For Empowerment ™ attracts volunteers together ... on clean water by empowering women as key stakeholders in the process. The ...
(Date:11/25/2015)... Neb. (PRWEB) , ... November 25, 2015 , ... ... staffing companies, has been recognized once again for its stellar workplace culture with ... to Work.” , Medical Solutions’ Cincinnati office was named a finalist ...
(Date:11/25/2015)... ... , ... Ministers, senior government and UN agencies, representatives from ... Excellence, and public R&D institutions, civil societies and other partners gathered today at ... Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day meeting ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 --> ... potential att använda SyMRI för att hitta ... patienter med multipel skleros (MS) eller hjärntumörmetastaser ... AB för att kunna använda SyMRI Research ... SyMRI kan man generera flera konstrastbilder från ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
Breaking Medicine Technology: